D. Stolz (Basel, Switzerland)
to present important clinical trials in respiratory medicine; to summarise key findings and discuss with the audience experts conclusions, to bring clinical trial’s abstracts into the clinical context. This session is led by a chair and two expert discussants who will facilitate the discussions and summarise key messages.
Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
G. Criner (Philadelphia, United States of America), B. Celli (Boston, United States of America), D. Singh (Manchester, United Kingdom), M. Jison (Gaithersburg, United States of America), N. Makulova (Gaithersburg, United States of America), V. Shih (Gaithersburg, United States of America), L. Brooks (Gaithersburg, United States of America), P. Barker (Gaithersburg, United States of America), U. Martin (Gaithersburg, United States of America), P. Newbold (Gaithersburg, United States of America)
|    |
Impact of endobronchial valves on patient reported outcomes in severe emphysema
M. Dransfield (Birmingham, United States of America), S. Bhatt (Birmingham, United States of America), D. Slebos (Groningen, Netherlands), K. Klooster (Groningen, Netherlands), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), J. Garner (London, United Kingdom), S. Radhakrishnan (Redwood City, United States of America), N. Shargill (Redwood City, United States of America), N. Marchetti (Philadelphia, United States of America), G. Criner (Philadelphia, United States of America)
| |
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
A. Valipour (Wien, Austria), A. Ing (Sydney1, Australia), J. Williamson (Sydney, Australia), T. Saghaie (Sydney, Australia), D. Steinfort (Melbourne, Australia), L. Irving (Melbourne, Australia), M. Fortin (Quebec, Canada), S. Martel (Quebec, Canada), G. Snell (Sydney, Australia), E. Dabscheck (Sydney, Australia), J. Waldstreicher (Melo Park, United States of America), W. Krimsky (Baltimore, United States of America), S. Fernandez-Bussy (Santiago, Chile)
| |
High-Flow Oxygen Therapy (HFOT) during training in COPD with chronic respiratory failure (CRF): a multicentre randomized controlled trial
M. Vitacca (Lumezzane, Italy), M. Paneroni (Lumezzane, Italy), E. Zampogna (Tradate, Italy), A. Spanevello (Tradate, Italy), P. Ceriana (Pavia, Italy), A. Carlucci (Pavia, Italy), P. Banfi (Milano, Italy), G. Pappacoda (Milano, Italy), L. Trianni (Gaiato, Italy), A. Brogneri (Gaiato, Italy), S. Belli (Veruno, Italy), E. Paracchini (Veruno, Italy), M. Aliani (Cassano delle Murge, Italy), V. Spinelli (Cassano delle Murge, Italy), F. Gigliotti (Firenze, Italy), B. Lanini (Firenze, Italy), M. Lazzeri (Milano, Italy), E. Clini (Modena, Italy), N. Ambrosino (Montescano, Italy)
|  |
Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT
H. Hansen (Copenhagen, Denmark), T. Bieler (Copenhagen, Denmark), N. Beyer (Copenhagen, Denmark), T. Kallemose (Hvidovre, Denmark), A. Frølich (Copenhagen, Denmark), N. Godtfredsen (Copenhagen, Denmark)
| |
Home initiation of chronic high-intensity noninvasive ventilation in COPD patients with chronic hypercapnic respiratory failure: the RECONSIDER trial.
M. Duiverman (Groningen, Netherlands), G. Bladder (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), J. Nieuwenhuis (Groningen, Netherlands), A. Hazenberg (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), P. Wijkstra (Groningen, Netherlands)
| |
Late Breaking Abstract - Phase 2a randomised, double-blind, placebo-controlled, crossover study of a novel P2X3 receptor antagonist S-600918 in patients with refractory chronic cough
A. Niimi (Nagoya, Japan), H. Ishihara (Osaka, Japan), H. Hida (Osaka, Japan), S. Miyazaki (Osaka, Japan)
| |
Wrap-up by discussant and discussion
F. Herth (Heidelberg, Germany)
| |